Parsley Health Grabs $26M in Series B

Parsley Health, the leading national provider of holistic personalized medicine designed to reverse chronic illness and optimize health, announced the launch of two new telemedicine services and a round of Series B funding today. Since Parsley Health's Series A in April of 2018, the company has raised an additional $26M in new funding.

White Star Capital, the global multi-stage technology investment platform, led the Series B round with additional investments from funds including FirstMark Capital, Amplo, Alpha Edison, Trail Mix Ventures, Arkitekt Ventures, and Galaxy Digital, as well as individuals including, Nat Turner, founder and CEO of Flatiron Health, and Tom Lee, Founder of One Medical. The Series B round officially closed in the summer of 2019.

Parsley Health was founded in 2016 by Dr. Robin Berzin MD, a Columbia-trained physician, digital health expert, and leader in functional medicine. Robin believes that medicine should put nutrition, wellness and prevention on the front lines of health care, while simultaneously making care smart and data-driven to meet our needs in today's world.